DEANNA BALLARD: Open Payments
NPI 1659733657 · DANBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,726 in 72 payments from 29 companies in 2025. Trend: 2023 $1,892 · 2024 $2,609 · 2025 $1,726
Food & beverage: $1,482Education: $244
| Company | Payments | Amount |
|---|---|---|
| Celgene Corporation | 14 | $196 |
| AstraZeneca Pharmaceuticals LP | 6 | $180 |
| ABBVIE INC. | 7 | $174 |
| Novartis Pharmaceuticals Corporation | 7 | $163 |
| Astellas Pharma US Inc | 2 | $121 |
| Aveo Pharmaceuticals, Inc. | 1 | $99 |
| SOBI, INC | 3 | $98 |
| Janssen Biotech, Inc. | 4 | $92 |
| PFIZER INC. | 4 | $88 |
| E.R. Squibb & Sons, L.L.C. | 3 | $76 |
Products named: REBLOZYL, OPDIVO, FOTIVDA, KISQALI, TAGRISSO, IMBRUVICA, EPKINLY, Fabhalta.
Industry payments across CT — which companies pay providers there.
